CIK 0001699350 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SHOULDER INNOVATIONS, INC.
Sign in to watch- Ticker
- SI
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270538764
- Phone
- 616-294-1026
- Business address
- 1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS, MI, 49507
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,246,952
- in 4 filings, $465K under 10b5-1 plans
Net −$1,246,952. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-04 | Gilde Healthcare Holding B.V. 10% owner | Sale | −99,812 | $22.77 | $2.3M | 2,221,640 |
| 2026-08-03 | Gilde Healthcare Holding B.V. 10% owner | Sale | −10,751 | $22.71 | $244K | 2,321,452 |
| 2026-07-31 | Gilde Healthcare Holding B.V. 10% owner | Sale | −20,034 | $22.73 | $455K | 2,332,203 |
| 2026-07-30 | Gilde Healthcare Holding B.V. 10% owner | Sale | −28,245 | $23.36 | $660K | 2,352,237 |
| 2026-06-26 | Sidow Kevin K. Director | Grant or award | +5,046 | 25,056 | ||
| 2026-06-26 | Hykes Andrew Director | Grant or award | +5,046 | 6,769 | ||
| 2026-06-26 | Buchholz Richard Director | Grant or award | +5,046 | 18,712 | ||
| 2026-06-26 | Tansey Casey M Director | Grant or award | +5,046 | 52,712 | ||
| 2026-06-26 | BUCKMAN PAUL Director | Grant or award | +5,046 | 63,750 | ||
| 2026-06-15 | Ahearn Matthew Fraser Chief Operating Officer | Sale 10b5-1 | −1,644 | $18.20 | $30K | 271,676 |
| 2026-06-15 | Ahearn Matthew Fraser Chief Operating Officer | Sale 10b5-1 | −2,500 | $19.26 | $48K | 269,176 |
| 2026-06-12 | Ahearn Matthew Fraser Chief Operating Officer | Sale 10b5-1 | −15,856 | $18.68 | $296K | 273,320 |
| 2026-04-30 | Ball Robert Joseph CEO & Executive Chairman | Option exercise | +10,000 | $2.48 | $25K | 300,018 |
| 2026-04-30 | Ball Robert Joseph CEO & Executive Chairman | Option exercise · Stock Option | −10,000 | 309,756 | ||
| 2026-04-20 | Ahearn Matthew Fraser Chief Operating Officer | Option exercise | +7,421 | $2.48 | $18K | 272,522 |
| 2026-04-20 | Ahearn Matthew Fraser Chief Operating Officer | Option exercise | +14,243 | $2.86 | $41K | 286,765 |
| 2026-04-20 | Ahearn Matthew Fraser Chief Operating Officer | Option exercise · Stock Option | −7,421 | 8,864 | ||
| 2026-04-20 | Ahearn Matthew Fraser Chief Operating Officer | Option exercise · Stock Option | −14,243 | 42,731 | ||
| 2026-03-13 | Ball Robert Joseph CEO & Executive Chairman | Purchase | +2,200 | $15.18 | $33K | 278,866 |
| 2026-03-13 | Buchholz Richard Director | Purchase | +1,000 | $14.84 | $15K | 13,666 |
Page 2 of 7 · 132 trades